Article

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

2021-12-15

Abstract excerpt

Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been recorded since January 2020. Over this time global vaccine programs have been introduced, contributing to lowered COVID-19 hospitalisation and mortality rates, particularly in the first world. In late 2021, the Omicron (B.1.1.529) virus variant emerged, with significant genetic differences and clinical eff...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3602767-255f-531f-a8d7-244ddfd690bd
DOI: 10.1101/2021.12.14.21267772

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernDOI 10.1101/2021.12.14.21267772Read

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernSemantic proximity Read

SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of ConcernSemantic proximity Read

Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2Semantic proximity Read

The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanismSemantic proximity Read

COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2Semantic proximity Read

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variantsSemantic proximity Read

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemicSemantic proximity Read

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesSemantic proximity Read

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine developmentSemantic proximity Read

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineagesSemantic proximity Read

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralizationSemantic proximity Read